Literature DB >> 19130901

Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy.

Christoph Kellinghaus1, Sascha Berning, Michael Besselmann.   

Abstract

Treatment of status epilepticus usually requires intravenous anticonvulsant therapy. Lacosamide is a novel anticonvulsant drug that is available as infusion solution. We describe a patient with nonconvulsive status epilepticus who was successfully treated with intravenous lacosamide.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19130901     DOI： 10.1016/j.yebeh.2008.12.009

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN： 1525-5050            Impact factor:   2.937


  22 in total

Review 1.  Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.

Authors:  Juan Luis Becerra; Joaquín Ojeda; Enrique Corredera; Jesús Ruiz Giménez
Journal:  CNS Drugs       Date:  2011-12-05       Impact factor: 5.749

2.  The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticus.

Authors:  Claude G Wasterlain; Thomas Stöhr; Alain Matagne
Journal:  Epilepsy Res       Date:  2011-01-28       Impact factor: 3.045

3.  Treatment of refractory status epilepticus in childhood.

Authors:  John M Schreiber; William D Gaillard
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

4.  Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures.

Authors:  Aatif M Husain; Jong W Lee; Bradley J Kolls; Lawrence J Hirsch; Jonathan J Halford; Puneet K Gupta; Yafa Minazad; Jennifer M Jones; Suzette M LaRoche; Susan T Herman; Christa B Swisher; Saurabh R Sinha; Adriana Palade; Keith E Dombrowski; William B Gallentine; Cecil D Hahn; Elizabeth E Gerard; Manjushri Bhapkar; Yuliya Lokhnygina; M Brandon Westover
Journal:  Ann Neurol       Date:  2018-06       Impact factor: 10.422

5.  Status epilepticus.

Authors:  Panayiotis N Varelas; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

6.  Successful treatment of refractory absence status epilepticus with lacosamide.

Authors:  Ulrik Sodemann; Harald Settergren Møller; Morten Blaabjerg; Christoph Patrick Beier
Journal:  J Neurol       Date:  2014-09-09       Impact factor: 4.849

7.  Safety and Efficiency of Intravenous Push Lacosamide Administration.

Authors:  K Erin Davidson; Joshua Newell; Khalid Alsherbini; Joseph Krushinski; G Morgan Jones
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

8.  The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill.

Authors:  C R Newey; N M Le; C Ahrens; P Sahota; S Hantus
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

9.  The safety of lacosamide for treatment of seizures and seizure prophylaxis in adult hospitalized patients.

Authors:  Marilyn E Luk; William O Tatum; Alden V Patel; Karen M Nau; William D Freeman
Journal:  Neurohospitalist       Date:  2012-07

10.  Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety.

Authors:  Christoph Kellinghaus
Journal:  Ther Clin Risk Manag       Date:  2009-09-24       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.